Concluded extraordinary transactions
Reserved Capital Increase
27 December 2024 | ILLUSTRATIVE REPORT OF THE BOARD OF DIRECTORS PREPARED PURSUANT TO ARTICLE 2441, CO. 6, ITALIAN CIVIL CODE, ON THE EXERCISE OF THE DELEGATION OF POWERS PURSUANT TO ARTICLE 2443, CO. 5, C.C. CONCERNING A RESERVED CAPITAL INCREASE | Download |
OPINION OF THE BOARD OF STATUTORY AUDITORS OF THE COMPANY ULISSE BIOMED S.P.A. ON THE APPROPRIATENESS OF THE ISSUE PRICE OF NEW SHARES (ART. 2441, PARAGRAPH 6, CIVIL CODE) | Download | |
27 November 2024 | ILLUSTRATIVE REPORT OF THE BOARD OF DIRECTORS PREPARED PURSUANT TO ARTICLE 2441, CO. 6, ITALIAN CIVIL CODE, ON THE EXERCISE OF THE DELEGATION OF POWERS PURSUANT TO ARTICLE 2443, CO. 5, C.C. CONCERNING A RESERVED CAPITAL INCREASE | Download |
OPINION OF THE BOARD OF STATUTORY AUDITORS OF THE COMPANY ULISSE BIOMED S.P.A. ON THE APPROPRIATENESS OF THE ISSUE PRICE OF NEW SHARES (ART. 2441, PARAGRAPH 6, CIVIL CODE) | Download | |
25 Setttembre 2024 | ILLUSTRATIVE REPORT OF THE BOARD OF DIRECTORS PREPARED PURSUANT TO ARTICLE 2441, CO. 6, ITALIAN CIVIL CODE, ON THE EXERCISE OF THE DELEGATION OF POWERS PURSUANT TO ARTICLE 2443, CO. 5, C.C. CONCERNING A RESERVED CAPITAL INCREASE | Download |
OPINION OF THE BOARD OF STATUTORY AUDITORS OF THE COMPANY ULISSE BIOMED S.P.A. ON THE APPROPRIATENESS OF THE ISSUE PRICE OF NEW SHARES (ART. 2441, PARAGRAPH 6, CIVIL CODE) | Download |
Capital increase under option
Application form for the option offer of ordinary shares of Ulisse Biomed S.p.A. (facsimile) | Download |
Notice of filing of option offer pursuant to Article 2441(2) of the Civil Code | Download |
KID for option rights with ISIN code IT0005576183 | Download |
Press release of 15 December 2023 - The Board of Directors partially exercises its proxy to increase the share capital under option | Download |
Press release of 21 December 2023 - Shareholders' meeting approves reverse take-over transaction and capital increase in kind to service it | Download |
Press release of 21 December 2023 - Deed of transfer of the entire shareholding in Hyris Limited in favour of Ulysses Biomed signed. Fulfilment of the condition to which the capital increase under option was subject. Co-optation of Stefano Lo Priore to replace resigning Chairman Saverio Scelzo | Download |
Press release of 22 December 2023 - Publication of the KID for option rights with ISIN code IT0005576183 | Download |
Press release of 23 January 2024 - Publication of the KID for the unexercised option rights with ISIN code IT0005576217 | Download |
KID for unexercised option rights with ISIN code IT0005576217 | Download |